AI Assistant
Blog
Pricing
Log In
Sign Up
Late phase II clinical test of irinotecan hydrochloride (CPT-11) for squamous cell carcinomas and malignant melanomas.
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
